Maintenance semi-metronomic oral cyclophospahamide and oral etoposide regimen in extensive stage small cell lung cancer (SCLC) patients after responding first line treatment

Ozdogan, M.Kargi, A.Artac, M.Bozcuk, H.Boruban, M. C.Coskun, H. S.Mutlu, H.2020-03-262020-03-2620091359-6349https://dx.doi.org/10.1016/S1359-6349(09)71844-0https://hdl.handle.net/20.500.12395/2366115th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology -- SEP 20-24, 2009 -- Berlin, GERMANY[Abstract not Available]en10.1016/S1359-6349(09)71844-0info:eu-repo/semantics/closedAccessMaintenance semi-metronomic oral cyclophospahamide and oral etoposide regimen in extensive stage small cell lung cancer (SCLC) patients after responding first line treatmentConference Object72544544WOS:000270645902476Q2